Keywords:
Multidisciplinary cancer care, Venous access, Ultrasound, Fluoroscopy, Veins / Vena cava, Oncology, Interventional vascular
Authors:
I. Jurca, R. Smiljanic, M. Prutki, A. M. Alduk; Zagreb/HR
DOI:
10.1594/ecr2018/C-0782
Results
A total of 159 port systems were implanted successfully in all consecutive patients who were referred to port system implantation between August 2015 and March 2017.
Among 159 patients (median age 58 years; range 22-82),
62 were women,
and 97 were men. The indication for port system implantation was chemotherapy in 157 patients (98,7%) and parenteral nutrition in two patients (1,3%).
Port systems were implanted in the right jugular vein (126/159; 79,3%),
left subclavian vein (11/159; 6,9%),
right subclavian vein (10/159; 6,3%),
left jugular vein (11/159; 6,9%),
and left common femoral vein (1/159; 0,6%).
The median port system duration time was 343 days (range 55-632).
A total of 0,15 complications per 1000 catheter days were detected (Fig.
8).
Early complications included hematoma (2/159; 1,3%).
Late complications included catheter associated venous thrombosis (2/159; 1,3%), catheter dislocation (1/159; 0,6%) and fibrin sheat formation (3/159; 1,8%) (Fig.
9).
No pneumothorax,
inadvertent arterial puncture or infection was detected.